White coat effect and white coat hypertension in pediatric patients

被引:31
|
作者
Matsuoka, S
Kawamura, K
Honda, M
Awazu, M
机构
[1] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan
[2] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Pediat Nephrol, Tokyo, Japan
关键词
white coat hypertension; white coat effect; ambulatory blood pressure monitoring; blood pressure;
D O I
10.1007/s00467-002-0990-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We evaluated the prevalence of white coat (WC) effect in pediatric age patients and that of white coat hypertension (WCH) in hypertensive pediatric patients. Two hundred and six patients (136 normotensive and 70 hypertensive patients, 107 boys and 99 girls, aged 6-25 years, mean 13.4, SD 4.7) were studied. Hypertension was diagnosed when systolic and/or diastolic blood pressure (BP) measurements with auscultatory technique were greater than or equal to the 95th percentile for sex and age. WC effect was defined as office BP minus daytime mean ambulatory BP (ABP). WCH was diagnosed in the hypertensive patients when daytime ABP values were < the 95th percentile for sex and height of reference values. There was a positive correlation between office BP and WC effect (P<0.05). A WC effect of greater than or equal to 10 mmHg was observed more frequently in hypertensive patients (50%) than in normotensive patients (25%). Among 70 hypertensive patients, 33 (47%) had WCH. There was no significant difference in the prevalence of WCH in relation to age, gender, or the presence or absence of causes of hypertension. In conclusion, WC effect is frequently seen in pediatric patients, and is more common in subjects with higher office BP.
引用
收藏
页码:952 / 955
页数:4
相关论文
共 50 条
  • [1] White coat effect and white coat hypertension in pediatric patients
    Seiji Matsuoka
    Ken Kawamura
    Masataka Honda
    Midori Awazu
    [J]. Pediatric Nephrology, 2002, 17 : 950 - 953
  • [2] White coat effect in patients with hypertension
    Andreeva, G. F.
    Gorbunov, V. M.
    Antipushina, D. N.
    Platonova, E., V
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (05) : 508 - 519
  • [3] WHITE COAT HYPERTENSION AND WHITE COAT EFFECT - SIMILARITIES AND DIFFERENCES
    VERDECCHIA, P
    SCHILLACI, G
    BORGIONI, C
    CIUCCI, A
    ZAMPI, I
    GATTOBIGIO, R
    SACCHI, N
    PORCELLATI, C
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (08) : 790 - 798
  • [4] WHITE COAT HYPERTENSION AND WHITE COAT EFFECT IN DIABETIC PATIENTS: COMORBIDITY AND NEW BIOMARKERS
    Hasslacher, C.
    Schaurer, T.
    Kulozik, F.
    [J]. JOURNAL OF HYPERTENSION, 2009, 27 : S360 - S360
  • [5] White coat effect and white coat hypertension in community pharmacy practice
    Botomino, A
    Martina, B
    Ruf, D
    Bruppacher, R
    Hersberger, KE
    [J]. BLOOD PRESSURE MONITORING, 2005, 10 (01) : 13 - 18
  • [6] WHITE COAT EFFECT AND WHITE COAT HYPERTENSION IN PATIENTS REFERRED TO AMBULATORY BLOOD PRESSURE MEASUREMENTS
    Foss, C.
    Hoieggen, A.
    Stenehjem, A. E.
    Os, I.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E456 - E456
  • [7] THE SUBCLINICAL INFLAMMATION IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION AND WHITE COAT HYPERTENSION
    Dziedzic-jankowska, Katarzyna
    Bujanowicz, Adam
    Szyszka, Michal
    Stelmaszczyk-emmel, Anna
    Skrzypczyk, Piotr
    [J]. JOURNAL OF HYPERTENSION, 2024, 42
  • [8] Detection of white coat hypertension and white coat effect in patients who visit community pharmacies in Andalusia
    Garcia Jimenez, Emilio
    Marin Magan, Francisco
    Virues Avila, Alberto
    Torres Antinolo, Amparo
    Espejo Guerrero, Jose
    Vaquero Prada, Juan Pedro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (02) : 496 - 496
  • [9] WHITE COAT HYPERTENSION
    SERWATKA, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (19): : 2847 - 2847
  • [10] WHITE COAT HYPERTENSION
    PENINGTON, GR
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1990, 152 (07) : 386 - 386